Avanos Medical Quarterly Income Statements Chart
Quarterly
|
Annual
Avanos Medical Quarterly Income Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net sales | 175,000,000 | 167,500,000 | 179,600,000 | 170,400,000 | 171,700,000 | 166,100,000 | 173,300,000 | 171,300,000 | 169,400,000 | 191,700,000 | 217,500,000 | 202,100,000 | 203,000,000 | 197,400,000 | 193,400,000 | 184,100,000 | 186,400,000 | 180,700,000 | 185,000,000 | 185,700,000 | 163,700,000 | 180,400,000 | 189,800,000 | 171,400,000 | 172,200,000 | 164,200,000 | 169,900,000 | 165,100,000 | 160,900,000 | 156,400,000 | -584,600,000 | 401,400,000 | 399,200,000 | 395,600,000 | 410,000,000 | 397,500,000 | 400,000,000 | 384,800,000 | 401,400,000 | 389,500,000 | 389,300,000 | 394,200,000 | 439,400,000 | 408,500,000 |
cost of products sold | 82,900,000 | 77,700,000 | 81,600,000 | 77,500,000 | 76,100,000 | 71,300,000 | 78,300,000 | 75,800,000 | 71,600,000 | 87,200,000 | 100,600,000 | 92,000,000 | 88,100,000 | 90,200,000 | 96,500,000 | 93,700,000 | 100,700,000 | 89,400,000 | 96,100,000 | 89,900,000 | 77,200,000 | 78,300,000 | 80,100,000 | 76,400,000 | 73,500,000 | 65,400,000 | 69,500,000 | 60,400,000 | 66,200,000 | 65,300,000 | -490,700,000 | 258,100,000 | 254,600,000 | 252,700,000 | 267,300,000 | 259,500,000 | 259,300,000 | 248,300,000 | 193,750,000 | 258,500,000 | 254,400,000 | 262,100,000 | 210,150,000 | 276,300,000 |
gross profit | 92,100,000 | 89,800,000 | 98,000,000 | 92,900,000 | 95,600,000 | 94,800,000 | 95,000,000 | 95,500,000 | 97,800,000 | 104,500,000 | 116,900,000 | 110,100,000 | 114,900,000 | 107,200,000 | 96,900,000 | 90,400,000 | 85,700,000 | 91,300,000 | 88,900,000 | 95,800,000 | 86,500,000 | 102,100,000 | 109,700,000 | 95,000,000 | 98,700,000 | 98,800,000 | 100,400,000 | 104,700,000 | 94,700,000 | 91,100,000 | -93,900,000 | 143,300,000 | 144,600,000 | 142,900,000 | 142,700,000 | 138,000,000 | 140,700,000 | 136,500,000 | 133,600,000 | 131,000,000 | 134,900,000 | 132,100,000 | 156,500,000 | 132,200,000 |
yoy | -3.66% | -5.27% | 3.16% | -2.72% | -2.25% | -9.28% | -18.73% | -13.26% | -14.88% | -2.52% | 20.64% | 21.79% | 34.07% | 17.42% | 9.00% | -5.64% | -0.92% | -10.58% | -18.96% | 0.84% | -12.36% | 3.34% | 9.26% | -9.26% | 4.22% | 8.45% | -206.92% | -26.94% | -34.51% | -36.25% | -165.80% | 3.84% | 2.77% | 4.69% | 6.81% | 5.34% | 4.30% | 3.33% | -14.63% | -0.91% | ||||
qoq | 2.56% | -8.37% | 5.49% | -2.82% | 0.84% | -0.21% | -0.52% | -2.35% | -6.41% | -10.61% | 6.18% | -4.18% | 7.18% | 10.63% | 7.19% | 5.48% | -6.13% | 2.70% | -7.20% | 10.75% | -15.28% | -6.93% | 15.47% | -3.75% | -0.10% | -1.59% | -4.11% | 10.56% | 3.95% | -197.02% | -165.53% | -0.90% | 1.19% | 0.14% | 3.41% | -1.92% | 3.08% | 2.17% | 1.98% | -2.89% | 2.12% | -15.59% | 18.38% | |
gross margin % | ||||||||||||||||||||||||||||||||||||||||||||
research and development | 5,800,000 | 5,400,000 | 5,700,000 | 7,200,000 | 6,300,000 | 7,000,000 | 6,800,000 | 6,100,000 | 6,800,000 | 7,900,000 | 7,500,000 | 7,300,000 | 8,000,000 | 7,800,000 | 7,600,000 | 8,400,000 | 8,000,000 | 8,300,000 | 9,600,000 | 8,200,000 | 7,700,000 | 9,400,000 | 8,400,000 | 9,600,000 | 9,500,000 | 10,200,000 | 10,600,000 | 10,500,000 | 10,800,000 | 9,900,000 | 10,100,000 | 10,300,000 | 9,800,000 | 8,000,000 | 12,000,000 | 10,900,000 | 9,500,000 | 8,700,000 | ||||||
selling and general expenses | 83,500,000 | 75,700,000 | 79,700,000 | 74,300,000 | 80,900,000 | 83,600,000 | 74,500,000 | 78,700,000 | 93,000,000 | 92,700,000 | 82,600,000 | 82,100,000 | 87,100,000 | 90,100,000 | 75,200,000 | 75,000,000 | 76,700,000 | 73,400,000 | 82,200,000 | 82,400,000 | 76,900,000 | 91,100,000 | 103,600,000 | 94,400,000 | 94,700,000 | 106,400,000 | 87,900,000 | 86,300,000 | 79,800,000 | 86,400,000 | 19,200,000 | 101,200,000 | 100,100,000 | 101,200,000 | 110,100,000 | 100,300,000 | 107,900,000 | 92,800,000 | 98,300,000 | 97,200,000 | 105,800,000 | 97,200,000 | 126,400,000 | 111,300,000 |
goodwill impairment | 77,000,000 | -1,500,000 | 475,500,000 | |||||||||||||||||||||||||||||||||||||||||
other income | 300,000 | -1,600,000 | -5,600,000 | -600,000 | 2,100,000 | 200,000 | 2,500,000 | 9,500,000 | 100,000 | 1,300,000 | 600,000 | 2,000,000 | 800,000 | 100,000 | -10,900,000 | 3,400,000 | 8,300,000 | 22,000,000 | 41,900,000 | 5,300,000 | 3,700,000 | 1,000,000 | 900,000 | 9,100,000 | 4,300,000 | 6,800,000 | 10,200,000 | 900,000 | -4,700,000 | 1,800,000 | 4,200,000 | 3,000,000 | 5,500,000 | 7,400,000 | -500,000 | 9,300,000 | 700,000 | -12,000,000 | ||||||
operating income | -74,500,000 | 10,300,000 | -418,500,000 | 12,000,000 | 6,300,000 | 4,000,000 | 11,200,000 | 1,200,000 | -2,100,000 | 2,600,000 | 26,200,000 | 18,700,000 | 19,000,000 | 9,200,000 | 25,000,000 | 3,600,000 | -7,300,000 | -44,800,000 | -100,000 | -1,800,000 | 600,000 | -3,200,000 | -18,100,000 | -9,800,000 | -24,600,000 | -8,300,000 | 7,000,000 | 8,800,000 | -7,000,000 | |||||||||||||||
yoy | -1282.54% | 157.50% | -3836.61% | 900.00% | -400.00% | 53.85% | -57.25% | -93.58% | -111.05% | -71.74% | 4.80% | 419.44% | -360.27% | -155.80% | -3700.00% | 305.56% | 1300.00% | -99.45% | -81.63% | -102.44% | -61.45% | -358.57% | -211.36% | 251.43% | ||||||||||||||||||||
qoq | -823.30% | -102.46% | -3587.50% | 90.48% | 57.50% | -64.29% | 833.33% | -157.14% | -180.77% | -90.08% | 40.11% | -1.58% | 106.52% | -63.20% | 594.44% | -149.32% | 44700.00% | -94.44% | -400.00% | -118.75% | -82.32% | 84.69% | -60.16% | 196.39% | -218.57% | -20.45% | -225.71% | |||||||||||||||||
operating margin % | ||||||||||||||||||||||||||||||||||||||||||||
interest income | 600,000 | 1,500,000 | 800,000 | 700,000 | 3,000,000 | 600,000 | 1,000,000 | 900,000 | 500,000 | 500,000 | 700,000 | 300,000 | 200,000 | 200,000 | 100,000 | 200,000 | 200,000 | 700,000 | 1,000,000 | 1,300,000 | 2,000,000 | 2,400,000 | 2,400,000 | 2,200,000 | 2,200,000 | 1,000,000 | 900,000 | 700,000 | 500,000 | 400,000 | 100,000 | 200,000 | 100,000 | 200,000 | 100,000 | 100,000 | 100,000 | 1,000,000 | ||||||
interest expense | -2,000,000 | -2,100,000 | -2,800,000 | -3,200,000 | -3,100,000 | -3,100,000 | -3,300,000 | -4,700,000 | -3,500,000 | -3,500,000 | -3,000,000 | -3,000,000 | -2,700,000 | -1,300,000 | -700,000 | -900,000 | -900,000 | -800,000 | -2,700,000 | -4,300,000 | -4,300,000 | -4,300,000 | -4,300,000 | -3,500,000 | -3,500,000 | -3,700,000 | -3,500,000 | -4,200,000 | -9,900,000 | -8,800,000 | -8,100,000 | -8,100,000 | -7,800,000 | -7,600,000 | -8,000,000 | -8,400,000 | -8,300,000 | -8,000,000 | -8,100,000 | -7,800,000 | -8,900,000 | -8,300,000 | -5,900,000 | -100,000 |
income before income taxes | -75,900,000 | 9,700,000 | -420,500,000 | 9,500,000 | 6,200,000 | 1,500,000 | 8,900,000 | -2,600,000 | -5,100,000 | -400,000 | 23,900,000 | 16,000,000 | 16,500,000 | 7,900,000 | 24,300,000 | 2,900,000 | -8,200,000 | -13,200,000 | -47,400,000 | -4,200,000 | -5,900,000 | -3,000,000 | -6,500,000 | -20,300,000 | -11,300,000 | -25,900,000 | -9,400,000 | 5,000,000 | 1,100,000 | -14,800,000 | -134,600,000 | 21,400,000 | 21,900,000 | 19,100,000 | 7,900,000 | 12,700,000 | 9,400,000 | 25,300,000 | 12,500,000 | -469,000,000 | 13,300,000 | 32,700,000 | 18,100,000 | 14,000,000 |
income tax provision | -900,000 | -3,100,000 | -1,625,000 | -3,600,000 | -100,000 | -3,975,000 | -4,800,000 | -4,800,000 | -6,300,000 | 2,100,000 | -3,600,000 | -2,900,000 | -11,100,000 | |||||||||||||||||||||||||||||||
income from continuing operations | -76,800,000 | 6,600,000 | -397,000,000 | 5,900,000 | 4,300,000 | 500,000 | 11,000,000 | -8,800,000 | -4,300,000 | -6,100,000 | -11,500,000 | -8,000,000 | -20,300,000 | -2,700,000 | 4,200,000 | 1,300,000 | -11,300,000 | |||||||||||||||||||||||||||
income from discontinued operations, net of tax | -300,000 | -1,600,000 | -2,500,000 | -1,400,000 | -500,000 | 5,100,000 | -63,800,000 | 500,000 | 34,000,000 | 31,500,000 | ||||||||||||||||||||||||||||||||||
net income | -76,800,000 | 6,600,000 | -397,300,000 | 4,300,000 | 1,800,000 | -900,000 | 10,500,000 | -3,700,000 | -68,100,000 | -500,000 | 16,900,000 | 15,700,000 | 11,400,000 | 5,800,000 | 10,000,000 | -35,100,000 | 37,900,000 | -7,600,000 | -47,200,000 | 19,300,000 | -3,000,000 | 3,700,000 | -6,100,000 | -11,500,000 | -8,000,000 | -20,300,000 | -2,200,000 | 4,200,000 | 35,300,000 | 20,200,000 | 32,800,000 | 16,600,000 | 17,100,000 | 12,800,000 | 10,000,000 | 9,100,000 | 6,500,000 | 14,200,000 | 14,500,000 | -470,500,000 | 8,000,000 | 21,700,000 | -2,400,000 | -7,400,000 |
yoy | -4366.67% | -833.33% | -3883.81% | -216.22% | -102.64% | 80.00% | -37.87% | -123.57% | -697.37% | -108.62% | 69.00% | -144.73% | -69.92% | -176.32% | -121.19% | -281.87% | -1363.33% | -305.41% | 673.77% | -267.83% | -62.50% | -118.23% | 177.27% | -373.81% | -122.66% | -200.50% | -106.71% | -74.70% | 106.43% | 57.81% | 228.00% | 82.42% | 163.08% | -9.86% | -31.03% | -101.93% | -18.75% | -34.56% | -704.17% | 6258.11% | ||||
qoq | -1263.64% | -101.66% | -9339.53% | 138.89% | -300.00% | -108.57% | -383.78% | -94.57% | 13520.00% | -102.96% | 7.64% | 37.72% | 96.55% | -42.00% | -128.49% | -192.61% | -598.68% | -83.90% | -344.56% | -743.33% | -181.08% | -160.66% | -46.96% | 43.75% | -60.59% | 822.73% | -152.38% | -88.10% | 74.75% | -38.41% | 97.59% | -2.92% | 33.59% | 28.00% | 9.89% | 40.00% | -54.23% | -2.07% | -103.08% | -5981.25% | -63.13% | -1004.17% | -67.57% | |
net income margin % | ||||||||||||||||||||||||||||||||||||||||||||
basic earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||
continuing operations | -1.66 | 0.14 | -8.63 | 0.13 | 0.09 | 0.01 | 0.24 | -0.19 | -0.09 | -0.12 | -0.24 | -0.17 | -0.43 | -0.06 | 0.09 | 0.03 | -0.24 | |||||||||||||||||||||||||||
discontinued operations | -0.01 | -0.03 | -0.05 | -0.03 | -0.01 | 0.11 | -1.37 | 0.01 | 0.72 | 0.67 | ||||||||||||||||||||||||||||||||||
basic earnings per share | -1.66 | 0.14 | -8.64 | 0.1 | 0.04 | 0.23 | -0.08 | -1.46 | -0.12 | -0.24 | -0.17 | -0.43 | -0.05 | 0.09 | 0.75 | 0.43 | ||||||||||||||||||||||||||||
diluted earnings per share: | ||||||||||||||||||||||||||||||||||||||||||||
diluted earnings per share | -1.66 | 0.14 | -8.64 | 0.09 | 0.04 | 0.23 | -0.08 | -1.46 | -0.12 | -0.24 | -0.17 | -0.43 | -0.05 | 0.09 | 0.73 | 0.43 | ||||||||||||||||||||||||||||
income tax benefit | -1,900,000 | -1,000,000 | 2,100,000 | -6,200,000 | 800,000 | -7,000,000 | -300,000 | -5,100,000 | -2,100,000 | -14,300,000 | -38,000,000 | 46,100,000 | 5,600,000 | 200,000 | 23,500,000 | 2,900,000 | 6,700,000 | 400,000 | 8,800,000 | 3,300,000 | 5,600,000 | 6,700,000 | -800,000 | 200,000 | 3,500,000 | |||||||||||||||||||
basic loss per share | -0.02 | |||||||||||||||||||||||||||||||||||||||||||
diluted loss per share | -0.02 | |||||||||||||||||||||||||||||||||||||||||||
earnings per share | ||||||||||||||||||||||||||||||||||||||||||||
basic | -0.01 | 0.178 | 0.34 | 0.24 | 0.12 | -0.025 | -0.73 | 0.79 | -0.16 | 0.105 | 0.4 | -0.06 | 0.08 | 0.25 | 0.35 | 0.37 | 0.27 | 0.21 | 0.19 | |||||||||||||||||||||||||
basic earnings per share | -1.66 | 0.14 | -8.64 | 0.1 | 0.04 | 0.23 | -0.08 | -1.46 | -0.12 | -0.24 | -0.17 | -0.43 | -0.05 | 0.09 | 0.75 | 0.43 | ||||||||||||||||||||||||||||
diluted | ||||||||||||||||||||||||||||||||||||||||||||
earnings per share | ||||||||||||||||||||||||||||||||||||||||||||
basic | -0.01 | 0.178 | 0.34 | 0.24 | 0.12 | -0.025 | -0.73 | 0.79 | -0.16 | 0.105 | 0.4 | -0.06 | 0.08 | 0.25 | 0.35 | 0.37 | 0.27 | 0.21 | 0.19 | |||||||||||||||||||||||||
diluted | -0.01 | 0.178 | 0.33 | 0.24 | 0.12 | -0.025 | -0.73 | 0.78 | -0.16 | 0.105 | 0.4 | -0.06 | 0.08 | 0.245 | 0.35 | 0.36 | 0.27 | 0.22 | 0.19 | |||||||||||||||||||||||||
operating profit | -12,400,000 | 21,075,000 | 28,800,000 | 29,200,000 | 26,300,000 | 15,800,000 | 20,900,000 | 17,600,000 | 33,100,000 | 20,500,000 | -461,200,000 | 22,100,000 | 40,900,000 | 24,000,000 | 13,100,000 | |||||||||||||||||||||||||||||
earnings per share | ||||||||||||||||||||||||||||||||||||||||||||
basic: | ||||||||||||||||||||||||||||||||||||||||||||
diluted: | ||||||||||||||||||||||||||||||||||||||||||||
other income and (income) | 4,800,000 | 5,900,000 | 5,700,000 | 1,900,000 | ||||||||||||||||||||||||||||||||||||||||
per share basis | ||||||||||||||||||||||||||||||||||||||||||||
basic | 0.14 | 0.3 | 0.31 | -10.1 | 0.17 | 0.47 | ||||||||||||||||||||||||||||||||||||||
diluted | 0.14 | 0.3 | 0.31 | -10.1 | 0.17 | 0.46 | ||||||||||||||||||||||||||||||||||||||
research and development expenses | 5,625,000 | 10,200,000 | 6,300,000 | 6,000,000 | 6,525,000 | 8,500,000 | ||||||||||||||||||||||||||||||||||||||
benefit from income taxes | 2,000,000 | -1,500,000 | -5,300,000 | -11,000,000 | -20,500,000 | -21,400,000 | ||||||||||||||||||||||||||||||||||||||
other (income) and expense | -1,400,000 | -700,000 |
We provide you with 20 years income statements for Avanos Medical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Avanos Medical stock. Explore the full financial landscape of Avanos Medical stock with our expertly curated income statements.
The information provided in this report about Avanos Medical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.